STAT

‘It’s been kind of rough’: At the epicenter of the pandemic, a Seattle ICU nurse treats two patients at a time

For a while, the Seattle ICU nurse was assigned one #Covid19 #coronavirus patient at a time, but "we’re back to our normal ratio again, because we’re getting more and more…

Stephanie Bandyk is on the front lines of the Covid-19 pandemic: A registered nurse who works in the intensive care unit of Seattle’s Swedish Hospital, she has helped treat some of the earliest patients infected with the novel coronavirus in the U.S. She has been working overnight shifts, from 7 p.m. to 7:30 a.m. in the state hardest hit by the new disease. There have been more than 1,000 cases of Covid-19 reported in Washington state, and at least 52 deaths.

In the most serious cases, the virulent pathogen has triggered severe pneumonia, and even multiple organ shutdown and death. Others in the Seattle area, as Bandyk points out, have had mild symptoms and have been able to self-treat at home.

STAT chatted with Bandyk about her experience in a Seattle ICU, as the coronavirus case count there steadily rises.

“The number of patients is just going to increase from here,” Bandyk said. “That’s just kind of how it is.”

The interview has been edited for clarity and length.

In recent days, the country and states have taken

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks